Evidence map›Paper›PMID 23397258›Full record

ArticleRheumatology international2014

Association study of CRP gene in systemic sclerosis in European Caucasian population.

Julien Wipff, Philippe Dieudé, Jérôme Avouac, Eric Hachulla, Jean-Luc Cracowski, Elisabeth Diot, Luc Mouthon, Jean Sibilia, Kiet Tiev, Olivier Meyer and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Julien WipffRhumatologie A, APHP, Hôpital Cochin, Université Paris Descartes, 27 Rue du faubourg St Jacques, 75014, Paris, France, julienwipff@gmail.com.
Philippe Dieudé
Jérôme Avouac
Eric Hachulla
Jean-Luc Cracowski
Elisabeth Diot
Luc Mouthon
Jean Sibilia
Kiet Tiev
Olivier Meyer
André Kahan
Catherine Boileau
Yannick Allanore
Université Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Grenoble · FRHôpital Ambroise-Paré · FRHôpital Bichat-Claude-Bernard · FRHôpital Cochin · FRHôpital d'Hautepierre · FRHôpital Saint-Antoine · FRInserm · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opsonization and apoptotic cell elements are critical in systemic lupus erythematosus (SLE) and could act through the activation of the innate immunity. C-reactive protein (CRP) belongs to opsonins, and polymorphisms of CRP gene have been shown to be associated with SLE susceptibility. Accumulating evidences show that SLE and systemic sclerosis (SSc) share some genetic susceptibility factors. To determine whether polymorphisms of CRP confer susceptibility to SSc, four SNPs (rs1130864, rs1205, rs1800947 and rs1341665), chosen using Hapmap linkage disequilibrium data and published data, were genotyped in a cohort of 651 SSc patients (569 with antinuclear antibodies, 258 with anti-centromere and 153 with anti-topoisomerase I) and 442 controls. All individuals were of French Caucasian origin. The four polymorphisms were in Hardy-Weinberg equilibrium in the control population. Allelic and genotypic frequencies for these four polymorphisms were found to be similar in SSc patients and controls. Moreover, subphenotype analyses in particular for subgroups having antinuclear antibodies did not detect any difference between SSc patients and controls. These results obtained through a large cohort of European Caucasian SSc patients do not support the implication of CRP gene in the pathogenesis of SSc.

Indexed as

AgedAntibodies, Anti-IdiotypicAntibodies, AntinuclearCase-Control StudiesC-Reactive ProteinDNA Topoisomerases, Type IEuropeFemaleFranceGenetic Predisposition to DiseaseGenotypeHumansLinkage DisequilibriumMaleMiddle AgedPolymorphism, Single NucleotideAntibodies, Anti-IdiotypicAntibodies, Antinuclearanticentromere antibodyC-Reactive ProteinDNA Topoisomerases, Type I

Identifiers

PMID23397258
OpenAlexW2056915619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.